Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.10
$4.65
$13.13
$1.10B1.471.14 million shs19.38 million shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$81.78
+0.1%
$83.84
$71.42
$109.58
$1.85B0.83170,475 shs467,754 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$60.22
+0.9%
$56.98
$47.04
$103.81
$3.30B1.1839,645 shs539,436 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$1.61
+10.3%
$1.38
$0.78
$2.24
$183.95M1.17965,699 shs783,102 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%0.00%0.00%+0.61%+129.51%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
+0.11%+0.80%+0.34%-2.05%-2.17%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+0.94%-0.68%+6.32%+3.65%-2.87%
The Beauty Health Company stock logo
SKIN
Beauty Health
+10.27%+5.23%+3.21%+22.90%-10.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.7582 of 5 stars
2.22.03.30.02.32.51.3
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.2475 of 5 stars
3.41.00.00.02.32.50.6
The Beauty Health Company stock logo
SKIN
Beauty Health
0.242 of 5 stars
0.80.00.00.01.53.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.20
Hold$12.75-2.71% Downside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$97.8319.63% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$90.0049.45% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
1.67
Reduce$1.42-12.01% Downside

Current Analyst Ratings Breakdown

Latest FNA, LMAT, PRCT, and SKIN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.50 ➝ $1.25
4/25/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $84.00
4/11/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $70.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$219.86M8.40$2.39 per share34.20$15.00 per share5.45
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$224.50M14.84N/AN/A$7.71 per share7.81
The Beauty Health Company stock logo
SKIN
Beauty Health
$334.30M0.61$0.07 per share23.09$0.41 per share3.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%N/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$44.04M$1.9841.3037.692.1619.96%13.53%9.78%7/30/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)

Latest FNA, LMAT, PRCT, and SKIN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million
5/1/2025Q1 2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.50$0.48-$0.02$0.48$57.61 million$59.87 million
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.800.98%N/A40.40%14 Years
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A

Latest FNA, LMAT, PRCT, and SKIN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.201%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.48
16.49
13.83
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75
The Beauty Health Company stock logo
SKIN
Beauty Health
12.01
7.47
6.43

Institutional Ownership

CompanyInstitutional Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
9.50%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.59 million20.45 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million51.68 millionOptionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030125.99 million74.34 millionOptionable

Recent News About These Companies

This ceramide secret transforms every skin type
Best Skin-Care Products for Black Skin

New MarketBeat Followers Over Time

Media Sentiment Over Time

Paragon 28 stock logo

Paragon 28 NYSE:FNA

$13.10 +0.02 (+0.11%)
Closing price 04/17/2025
Extended Trading
$13.10 0.00 (0.00%)
As of 04/17/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$81.78 +0.09 (+0.11%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$81.82 +0.03 (+0.04%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$60.22 +0.56 (+0.94%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$60.32 +0.10 (+0.16%)
As of 06/20/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$1.61 +0.15 (+10.27%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.60 -0.01 (-0.31%)
As of 06/20/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.